Nikki J
Moderator
- Joined
- Mar 22, 2012
- Messages
- 16,378
- Reason
- PALS
- Diagnosis
- 04/2014
- Country
- US
- State
- MA
- City
- Boston
Cytokinetics plans to take Lou Gehrig's disease drug into late-stage study - San Francisco Business Times
If you remember this showed some possible respiratory benefit in phase 2 but did not slow decline in ALSFRS scores.
And we have been disappointed before when a drug went from phase 2 to 3 but still it seems like today is a day for hopeful reports ( and not owing anything to IBC so I pray this is just the beginning)
If you remember this showed some possible respiratory benefit in phase 2 but did not slow decline in ALSFRS scores.
And we have been disappointed before when a drug went from phase 2 to 3 but still it seems like today is a day for hopeful reports ( and not owing anything to IBC so I pray this is just the beginning)